STARLING ONCOLOGY INC
STLNNASDAQ๐ #3146 by market capEarnings Mar 10 ยท PostUS Equity
โโ
Quote unavailableTrack STLN
Get earnings, price moves & breaking news on Telegram
24hโ
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$306M
Small Cap
๐Revenue Growth (YoY)
38.4%
High Growth
๐Gross Margin
15.7%
Thin
๐ตFCF Margin
2.2%
Thin
โ๏ธP/S Ratio
0.5x
Cheap
Otter Score
โ
Insufficient data
No chart data available for STLN.
Trading Snapshot
- Day Range
- โ
- 52-Week Range
- $3.13 โ $7.13
- Volume (shares)
- โ
- Avg Volume (shares)
- โ
- Shares Outstanding
- 101.9M
- Next Earnings
- 2027-03-10
Fundamentals Snapshot
- Annual Revenue
- $503M
- Last Q Revenue
- $170M
- P/E Ratio
- โ
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.36
- Dividend Yield
- โ
STARLING ONCOLOGY INC
STLNFinancial Trends
Financial history unavailable.
About STARLING ONCOLOGY INC
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
๐Qualityโ
โ
โ
โ
โ
๐Growthโ
โ
โ
โ
โ
โ๏ธValuationโ
โ
โ
โ
โ
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.